SYLVATICA BIOTECH INC
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.9Mattributed |
|---|---|
| Latest round | grant, $1.9M, 2024-09-01attributed |
| Founded | 2017 |
| Headquarters | NORTH CHARLESTON, South Carolina, USA |
| Industry | healthtech |
| Stage | unknown |
| Website | sylvaticabio.com |
Sylvatica Biotech develops supercooling technology to preserve donor organs and tissues at subzero temperatures without freezing. It serves transplant centers, organ procurement organizations, and regenerative medicine companies needing longer preservation windows. Its approach has extended human liver preservation by multiple days, enabling successful transplants where conventional cold storage would have ruled the organ ineligible.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-01 | grant | $1.9M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Squarespace, Squarespace Commerce, Stimulus, web-vitals, moment 0, @sentry/browser
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.9M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | sylvaticabio.com, read 2026-05-07 |
| Description | self-reported | sylvaticabio.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.